Skip to main content
. 2019 Nov-Dec;35(6):1647–1651. doi: 10.12669/pjms.35.6.1287

Table I.

Clinical Data of Study Population (n=52).

Variable Total n=52 Group A (FTO Group) n=25 Group B (PTO Group) n=27 p Value (Between groups)
Age (Years) mean ± SD 11.06±3.30 10.68±3.29 11.41± 3.34 0.433*
Gender
 Male 17(65.4%) 9(69.2%) 8(61.5%) 0.560**
 Female 9 (34.6%) 4(30.8%) 5(38.5%)
Pre-treatment BCVA (logMAR) mean ± SD 0.70±0.20 0.70±0.20 0.70±0.21 0.945*
Post-treatment BCVA (logMAR) mean ± SD 0.29±0.18 0.23±0.15 0.35±0.20 0.023*
Improvement in Lines on Snellen’s Chart (no) mean ± SD 1.92±1.35 2.20±1.38 1.67±1.30 0.158*
*

Independent ‘t’ Test

**

Chi Square test.